Cargando…

Impact of biologics on growth in children with juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Uettwiller, F, Pinto, G, Polak, M, Quartier, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194490/ http://dx.doi.org/10.1186/1546-0096-9-S1-P139

Ejemplares similares

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
por: Remy Piccolo, V, et al.
Publicado: (2013)

Juvenile idiopathic arthritis treated with biological therapies
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Eight years of experience with biological treatment in juvenile idiopathic arthritis
por: Mourão, A F, et al.
Publicado: (2010)

Renal disorder and biological treatment in juvenile idiopathic arthritis
por: Mateescu, Lidia, et al.
Publicado: (2014)

A biopsychosocial approach to parents of children with juvenile idiopathic arthritis
por: Georgiadou, Z, et al.
Publicado: (2011)

The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis
por: Trachana, M, et al.
Publicado: (2011)

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
por: Murias, S, et al.
Publicado: (2011)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
por: Woerner, A, et al.
Publicado: (2015)

35 Pharmacologic management of children with juvenile idiopathic arthritis in Batna, Algeria
por: Hadef,, et al.
Publicado: (2022)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
por: Melki, I, et al.
Publicado: (2011)

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
por: Remesal, A, et al.
Publicado: (2011)

Genetic susceptibility to juvenile idiopathic arthritis in Iranian children
por: Shiari, Reza, et al.
Publicado: (2011)

Temporomandibular joint involvement in children with juvenile idiopathic arthritis
por: Cannizzaro, E, et al.
Publicado: (2008)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg
por: Kingsbury, D, et al.
Publicado: (2013)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
por: Nikishina, I, et al.
Publicado: (2008)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
por: Otten, MH, et al.
Publicado: (2013)

Pain experience in children with juvenile idiopathic arthritis on TNFalpha-inhibitors
por: Jeppesen, JH, et al.
Publicado: (2008)

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
por: Alfantaki, SA, et al.
Publicado: (2011)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
por: Rokhlina, FV, et al.
Publicado: (2011)

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

Superoxide dismutase and and its isoenzymes in children with juvenile idiopathic arthritis
por: Zielinska, Henryka Mazur, et al.
Publicado: (2014)

Juvenile idiopathic arthritis: the transition to adulthood
por: Fernandes, Susana, et al.
Publicado: (2014)

PReS-FINAL-2315: Severe cutaneous vasculitis in two patients with juvenile idiopathic arthritis and biologic therapy
por: Falcini, F, et al.
Publicado: (2013)

Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients
por: Ruperto, N, et al.
Publicado: (2008)

Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
por: Schou, AJ, et al.
Publicado: (2011)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
por: Tzaribachev, N, et al.
Publicado: (2008)

Emotion regulation predicts pain and functioning in children with juvenile idiopathic arthritis
por: Connelly, Mark, et al.
Publicado: (2012)

Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals
por: Arsenyeva, Svetlana V, et al.
Publicado: (2014)

Multicenter retrospective study of biological tolerance in juvenile idiopathic arthritis (jir-cohort)
por: Cabrera, Natalia, et al.
Publicado: (2014)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fodj2qjg2suppk08200vh3jqbo